Page last updated: 2024-10-21

enprofylline and Cough

enprofylline has been researched along with Cough in 1 studies

enprofylline : Xanthine bearing a propyl substituent at position 3. A bronchodilator, it is used for the symptomatic treatment of asthma and chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.

Cough: A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Forsberg, K1
Karlsson, JA1
Zackrisson, C1
Persson, CG1

Other Studies

1 other study available for enprofylline and Cough

ArticleYear
Selective inhibition of cough and bronchoconstriction in conscious guinea pigs.
    Respiration; international review of thoracic diseases, 1992, Volume: 59, Issue:2

    Topics: Animals; Antitussive Agents; Bronchoconstriction; Bronchodilator Agents; Citrates; Citric Acid; Coug

1992